BMC BioinformaticsBioinformaticsPeer-reviewed journal article
Probabilistic modeling methods for cell-free DNA methylation based cancer classification
Abstract
BackgroundcfMeDIP-seq is a low-cost method for determining the DNA methylation status of cell-free DNA and it has been successfully combined with statistical methods for accurate cancer diagnostics. We investigate the diagnostic classification aspect by applying statistical tests and dimension reduction techniques for feature selection and probabilistic modeling for the cancer type classification, and we also study the effect of sequencing depth. MethodsWe experiment with a variety of statistical methods that use different feature selection and feature extraction methods as well as probabilistic classifiers for diagnostic decision making. We test the (moderated) t-tests and the Fishers exact test for feature selection, principal component analysis (PCA) as well as iterative supervised PCA (ISPCA) for feature generation, and GLMnet and logistic regression methods with sparsity promoting priors for classification. Probabilistic programming language Stan is used to implement Bayesian inference for the probabilistic models. Results and conclusionsWe compare overlaps of differentially methylated genomic regions as chosen by different feature selection methods, and evaluate probabilistic classifiers by evaluating the area under the receiver operating characteristic (AUROC) scores on discovery and validation cohorts. While we observe that many methods perform equally well as, and occasionally considerably better than, GLMnet that was originally proposed for cfMeDIP-seq based cancer classification, we also observed that performance of different methods vary across sequencing depths, cancer types and study cohorts. Overall, methods that seem robust and promising include Fishers exact test and ISPCA for feature selection as well as a simple logistic regression model with the number of hyper and hypomethylated regions as features.
- Citations
- 6
- FWCI
- 0.41
- Field percentile
- 49th percentile
- Gene expression and cancer classification
- Epigenetics and DNA Methylation
- Cancer Genomics and Diagnostics
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA
Anna Bergamaschi, Yuhong Ning, … Samuel Levy·medRxiv·Jan 22, 2020
- cfMIND: A read-level methylation framework for accurate non- invasive disease detection using cell-free DNA
- MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis
Yong Zeng, Wenbin Ye, … Housheng Hansen He·BioinformaticsPeer-reviewed·Jul 1, 2023
- Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from Methylated DNA Sequencing data (MeD-seq)
Daan M. Hazelaar, Ruben Boers, … Saskia M. Wilting·npj Precision OncologyPeer-reviewed·Dec 15, 2025
- MetDecode: methylation-based deconvolution of cell-free DNA for non-invasive multi-cancer typing
Antoine Passemiers, Stefania Tuveri, … Joris Robert Vermeesch·BioinformaticsPeer-reviewed·Aug 22, 2024
- Development of methylation-based biomarkers for breast cancer detection by model training and validation in synthetic cell-free DNA
S. M. de Proce, M. Adamowicz, … T. J. Aitman·bioRxiv·Feb 11, 2022